Cooper Companies COO
NASDAQ COO
$53.91 -0.26 (-0.48%)
At close: Sep 11, 2026 · 4:00 PM EDT

Cooper Companies (COO) Non-Current Deffered Revenue (2021 - 2026)

Cooper Companies (COO) posted Non-Current Deffered Revenue of $208.8 million for Q2 2026, up 1.16% on a QoQ basis from $206.4 million in Q1 2026, and up 6.31% year-over-year from $196.4 million in Q2 2025.

Analysis

Cooper Companies (COO) Non-Current Deffered Revenue (2021 - 2026) Analysis & Trends

Cooper Companies has reported Non-Current Deffered Revenue for 6 years, with the latest figure at $208.8 million in Q2 2026.

  • On a quarterly basis, Non-Current Deffered Revenue rose 6.31% year-over-year to $208.8 million in Q2 2026; TTM through Apr 2026 was $208.8 million, a 6.31% increase from a year earlier, with the FY2025 full-year figure at $201.8 million, up 4.4% from the prior year.
  • Non-Current Deffered Revenue was $208.8 million for Q2 2026 at Cooper Companies, up from $206.4 million in the prior quarter.
  • The five-year high for Non-Current Deffered Revenue was $208.8 million in Q2 2026, with the low at $182.6 million in Q2 2023.
  • Average Non-Current Deffered Revenue over 5 years is $194.1 million, with a median of $193.4 million recorded in 2025.
  • The sharpest annual moves came in 2022 and 2023: Non-Current Deffered Revenue jumped 198200.0% in 2022, then dropped 7.11% in 2023.
  • Over 5 years, Non-Current Deffered Revenue stood at $198.3 million in 2022, then decreased by 7.11% to $184.2 million in 2023, then increased by 4.94% to $193.3 million in 2024, then climbed by 4.4% to $201.8 million in 2025, then grew by 3.47% to $208.8 million in 2026.
  • The last three Non-Current Deffered Revenue figures came in at $208.8 million (Q2 2026), $206.4 million (Q1 2026), and $201.8 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Abbott Laboratories 178.01 Bn 172.41 Bn 7.27 Bn -
2 Intuitive Surgical 131.29 Bn 126.08 Bn 1.96 Bn -
3 Medtronic 116.38 Bn 107.56 Bn 6.34 Bn -
4 Stryker 106.01 Bn 102.53 Bn 4.50 Bn -
5 Boston Scientific 63.40 Bn 62.86 Bn 3.85 Bn -
6 Edwards Lifesciences 48.89 Bn 44.64 Bn 1.35 Bn -
7 Alcon 32.59 Bn 31.13 Bn 1.68 Bn -
8 Dexcom 31.84 Bn 29.89 Bn 830.00 Mn -
9 Steris 20.61 Bn 20.13 Bn 684.20 Mn -
10 Cooper Companies 10.51 Bn 10.37 Bn 735.40 Mn 208.80 Mn
Historic Data

Historic Data

Download Data
DateValue
Apr 30, 2026 208.80 Mn
Jan 31, 2026 206.40 Mn
Oct 31, 2025 201.80 Mn
Jul 31, 2025 199.40 Mn
Apr 30, 2025 196.40 Mn
Jan 31, 2025 193.40 Mn
Oct 31, 2024 193.30 Mn
Jul 31, 2024 190.80 Mn
Apr 30, 2024 188.60 Mn
Jan 31, 2024 186.30 Mn
Oct 31, 2023 184.20 Mn
Jul 31, 2023 185.50 Mn
Apr 30, 2023 182.60 Mn
Jan 31, 2023 195.10 Mn
Oct 31, 2022 198.30 Mn
Oct 31, 2021 100,000.00